Pill Talk: Negotiating, Lobbying, and Inflating Drug Prices
From 2000 to 2020, the government increased its spending on prescription drugs by 91 percent, now it's trying to rein in costs.
CFTC Whistleblowers: An Underfunded Program For an Underfunded Agency
The CFTC deserves a long-term solution that will adequately support the awards program and thus incentivize whistleblowers.
Based on Past, DOJ’s New Whistleblower Program Could Yield Big Recoveries for Taxpayers
The DOJ recently launched a new Whistleblower Award Program, and we take a look to see what it could recover with robust whistleblower participation.
Troublesome Trends in Crypto Crime
As of 2023, crypto fraud is the riskiest scam, with the second-highest median dollar loss for consumers in the United States.
Fraud is Taxable, Too!
The IRS could collect another $76.86 billion in unpaid taxes and the IRS Whistleblower Program can help fill the gap.
Kickbacks Come in All Shapes and Sizes
In just the first six months of 2024, the DOJ announced eleven enforcement actions recovering nearly $140 million alleging Anti-Kickback Statute violations.
The “Why” of SEC Whistleblower Awards: Analyzing the Rationale for Denials and Award Amounts in the SEC Whistleblower Program in 2024
In just 8 months, the SEC Whistleblower Program has given out 46 awards, so we take a look at some of the common themes.
How Fraudsters Are Taking Advantage – of Medicare Advantage
The money spent on Medicare Advantage could have paid for 4.5 million traditional Medicare beneficiaries for an entire year.
The Supreme Court Will Consider What Constitutes a “Claim” Under the False Claims Act
The Supreme Court will be looking
Telehealth: A New Trend in both Healthcare and Healthcare Fraud
Telehealth fraud spread "like wildfire" during the pandemic, and enforcement actions are still being brought against fraudsters.
